Sandoz prepares early 2019 launch for EpiPen alternative Symjepi at 16% discount

Sandoz prepares early 2019 launch for EpiPen alternative Symjepi at 16% discount

Submitted by admin on December 6, 2018 - 1:04pm
Source: 
Fierce Pharma
News Tags: 
Novartis
Sandoz
generics
Symjepi
EpiPens
Teva Pharmaceutical
Mylan
Headline: 
Sandoz prepares early 2019 launch for EpiPen alternative Symjepi at 16% discount
snippet: 
Following an EpiPen generic launch by Teva, Novartis' Sandoz has released its launch plans for epinephrine alternative Symjepi. The drug will launch at a slight discount to Teva's product.

Do Not Allow Advertisers to Use My Personal information